According to the TGCA database, about 14%, 11%, and 9% of lung cancer possess mutations in Kelch Like ECH Associated Protein 1 (KEAP1), Neurofibromatosis type 1 (NF1), and Epidermal growth factor receptor (EGFR), respectively. This evidence concerns the gene KEAP1 and lung carcinoma.